Disc Medicine Inc. Common Stock (IRON)
Stock · NASDAQ · Health Care
$80.01as of 8/28/2026
Price chart
Open in TradingViewActive signals
About IRON
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formati…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 165
- Website
- www.discmedicine.com/
Fundamentals
- 1-day range
- $79.77$82.64
- Market cap
- $2.97B
- P/E (trailing)
- —
- P/E (forward)
- -11.02
- EPS (trailing)
- $-6.57
- Dividend yield
- —
- Beta
- 0.90
- Avg. volume
- 524.6K
Forecasts
12 analyst ratings
Disc Medicine Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- IRONDisc Medicine Inc. Common Stock$80.01▼ 3.08%Market cap $2.97BP/E —$40$99.5
- IMNMImmunome Inc. Common Stock$27.57▼ 4.50%Market cap $2.92BP/E —$8.67$30.06
- MBXMBX Biosciences Inc. Common Stock$63.04▼ 5.05%Market cap $3.19BP/E —$9.63$72.64
- SUPNSupernus Pharmaceuticals Inc. Common Stock$43.76▼ 0.97%Market cap $2.72BP/E —$42.45$59.68
- NAMSNewAmsterdam Pharma Company N.V. Ordinary Shares$25.9▼ 3.32%Market cap $3.23BP/E —$23.05$42.21
- ARQTArcutis Biotherapeutics Inc. Common Stock$23.78▼ 4.38%Market cap $3.31BP/E 113.86$15.1$31.77
- TRVITrevi Therapeutics Inc. Common Stock$16.78▼ 6.60%Market cap $2.63BP/E —$6.93$20.22
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| IRON Disc Medicine Inc. Common Stock | $2.97B | — | $80.01 | ▼ 3.08% | $40$99.5 |
| IMNM Immunome Inc. Common Stock | $2.92B | — | $27.57 | ▼ 4.50% | $8.67$30.06 |
| MBX MBX Biosciences Inc. Common Stock | $3.19B | — | $63.04 | ▼ 5.05% | $9.63$72.64 |
| SUPN Supernus Pharmaceuticals Inc. Common Stock | $2.72B | — | $43.76 | ▼ 0.97% | $42.45$59.68 |
| NAMS NewAmsterdam Pharma Company N.V. Ordinary Shares | $3.23B | — | $25.9 | ▼ 3.32% | $23.05$42.21 |
| ARQT Arcutis Biotherapeutics Inc. Common Stock | $3.31B | 113.86 | $23.78 | ▼ 4.38% | $15.1$31.77 |
| TRVI Trevi Therapeutics Inc. Common Stock | $2.63B | — | $16.78 | ▼ 6.60% | $6.93$20.22 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →- Yu Jonathan Yen-Wen · August 25, 2026 · Option Exercise8.8K @ $13.5
- Yu Jonathan Yen-Wen · August 25, 2026 · Sale8.8K @ $83.12
- Yu Jonathan Yen-Wen · August 24, 2026 · Option Exercise300 @ $13.5
- Yu Jonathan Yen-Wen · August 24, 2026 · Sale300 @ $82.53
- Yu Jonathan Yen-Wen · August 12, 2026 · Option Exercise804 @ $13.5
- Yu Jonathan Yen-Wen · August 12, 2026 · Sale804 @ $82.64
- Khara Rahul · August 6, 2026 · Option Exercise5.0K @ $14.69
- Khara Rahul · August 6, 2026 · Sale5.0K @ $80
- Quisel John D · July 13, 2026 · Option Exercise7.4K @ $13.5
- Quisel John D · July 13, 2026 · Option Exercise25.6K @ $9.86
- Quisel John D · July 13, 2026 · Sale6.4K @ $76.05
- Quisel John D · July 13, 2026 · Sale16.9K @ $74.95
- Quisel John D · July 13, 2026 · Sale9.7K @ $74.27
- Yu Jonathan Yen-Wen · July 7, 2026 · Option Exercise100 @ $13.5
- Yu Jonathan Yen-Wen · July 7, 2026 · Sale100 @ $82.5
Institutional Ownership
March 31, 2026
- Total shares held
- 40.46M
- Total value held
- $2.48B
- Institutional holders
- 200
- Unknown5.59M
- Unknown2.45M
- Unknown2.27M
- Unknown1.74M
- Unknown1.70M
- Unknown1.55M
- Unknown1.51M
- Unknown1.38M
- Unknown1.35M
- Unknown1.34M
See the full, filterable feed with live charts on the MarketWall dashboard.